Clinical Trial Update: Determining Prognostic Immune Markers in Patients With Ovarian Cancer

View source ↗

Summary

A clinical trial at Leiden University Medical Center is recruiting to identify prognostic immune markers in epithelial ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Snippet

Sponsor: Leiden University Medical Center | Conditions: Epithelial Ovarian Cancer | Status: RECRUITING